Tripti Mishra

Title: Tripti Mishra: Research and Patent on Benign Prostatic Hyperplasia

Introduction

Tripti Mishra is an inventor associated with the Council of Scientific and Industrial Research in Lucknow, India. Her patent work concerns plant-derived compounds and their potential application in managing benign prostatic hyperplasia (BPH).

Latest Patents

Mishra is listed as an inventor on 1 patent: “Chebulinic acid and its enriched fraction from the fruits of [plant name not specified] for treatment of benign prostatic hyperplasia (BPH) and its preparation thereof.” The invention describes the beneficial effects of chebulinic acid (CA) and a standardized, enriched fraction of chebulinic acid (CAEF) prepared from fruit for BPH management. It also presents a method for isolating chebulinic acid and ellagic acid from dried, powdered fruit without relying on costly or labor-intensive techniques such as HPLC, column chromatography, or resins. The supplied patent description does not identify the plant species.

Career Highlights

Mishra’s listed patent reflects research into natural compounds, their preparation, and their potential therapeutic use. The described isolation method aims to offer a convenient and economically viable alternative to more complex chromatographic approaches.

Collaborations

The patent lists Narender Tadigoppula and Monika Sachdev as Mishra’s coworkers. The work is associated with the Council of Scientific and Industrial Research.

Conclusion

Tripti Mishra’s patent focuses on chebulinic acid and its enriched fraction as potential tools for BPH management, alongside a more accessible method for isolating the relevant compounds.